CVS Stock Recent News
CVS LATEST HEADLINES
CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The rate adds more pressure on insurers already grappling with high medical costs and uncertainty after the cyberattack on UnitedHealth Group's tech unit.
Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Some large health insurers in the U.S. will start covering Wegovy, which has become a popular anti-obesity drug — but not for those using it to lose weight, according to a report by The Wall Street Journal.
CVS Health (CVS) concluded the recent trading session at $79.43, signifying a +0.14% move from its prior day's close.
Malcolm Ethridge, CIC Wealth Executive Vice President, joins 'Power Lunch' to discuss his investing take on three stocks: Visa, McCormick, and CVS.